ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Ideal Versus Total Body Weight Dosing of Rabbit Anti-Thymocyte Globulin Induction Therapy on Patient Outcomes in High Immunological Risk Kidney Transplant

M. Vacha, J. Gommer, A. Rege, S. Sanoff, D. Sudan, M. Harris.

Duke University Hospital, Durham, NC.

Meeting: 2015 American Transplant Congress

Abstract number: A151

Keywords: Antilymphocyte antibodies, Dosage

Session Information

Date: Saturday, May 2, 2015

Session Name: Poster Session A: Kidney Immunosuppression: Induction Therapy

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Related Abstracts
  • Kidney Patients at High Immunological Risk Can Be Safely Transplanted With a Novel Induction Regimen Using Anti-Thymocyte Globulin (Rabbit) (rATG) Plus Basiliximab
  • Dichotomous T-Cell Repopulation after Anti-Thymocyte Globulin Induction Therapy in High Immunological Risk and DCD Renal Transplant Recipients

Background

The optimal dose of rabbit anti-thymocyte globulin (rATG) induction therapy in high immunological risk kidney transplantation (KTx) lacks consensus and the effect of dosing weight has not been evaluated. Before 2009, high immunologic risk KTx recipients, defined as panel reactive antibody greater than 40%, 2nd KTx with early loss, or 3rd and greater KTx, received a 5-day total rATG dose of 7.5 mg/kg using total body weight (TBW). In 2009, this dosing strategy was modified to utilize ideal body weight (IBW).

Methods and materials

This retrospective, single-center cohort study included all adult high immunologic risk KTx recipients from 1/1/2006 to 10/31/2012 who received 5 doses of rATG for induction therapy, excluding those who had a dose reduction due to leukopenia or thrombocytopenia. All patients were discharged on tacrolimus, mycophenolate, and prednisone. Clinical outcomes were evaluated between the TBW and IBW dosing strategies by using an a priori proxy marker of cumulative dose of 7.5 mg/kg TBW to separate patients into two groups. The primary endpoint was rate of first biopsy-proven acute rejection (BPAR) within the first 90 days post-KTx.

Results

Eighty-nine patients were included. Baseline demographics were similar between groups except for mean TBW was significantly higher in the IBW cohort (86.4 kg vs. 75.7 kg; p = 0.009) and cumulative rATG dose per TBW was significantly less for the IBW cohort (6.7 mg/kg vs. 8.1 mg/kg TBW; p < 0.001). Rate of BPAR at 90-days and 1-year were similar between IBW and TBW cohorts (90-days, 4.2% vs. 0%, p =0.5; 1-year, 8.7% vs. 0%, p = 0.13). Patient survival and renal function were also similar. Median cost of rATG therapy per patient was less in the IBW cohort; however, this was not statistically significant ($17,542 vs. $19,934; p = 0.3).

Conclusion

Our results suggest that use of IBW for dose calculations of rATG induction therapy in high immunological risk KTx at 7.5 mg/kg provides low rates of acute rejection with a similar safety profile as that of a TBW-dosed regimen. Use of IBW for lower cumulative doses may still need further evaluation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Vacha M, Gommer J, Rege A, Sanoff S, Sudan D, Harris M. Ideal Versus Total Body Weight Dosing of Rabbit Anti-Thymocyte Globulin Induction Therapy on Patient Outcomes in High Immunological Risk Kidney Transplant [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/ideal-versus-total-body-weight-dosing-of-rabbit-anti-thymocyte-globulin-induction-therapy-on-patient-outcomes-in-high-immunological-risk-kidney-transplant/. Accessed February 27, 2021.

« Back to 2015 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.